Elanco
North America, Indiana, United States, Greenfield
Description
Elanco develops, manufactures and markets products for companion and food animals.
Investor Profile
Elanco has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Corporate Round, Seed rounds (top funding stages).
- Majority of deals are located in United States, Switzerland.
- Strong thematic focus on Biotechnology, AgTech, Therapeutics.
Stage Focus
- Series A (40%)
- Corporate Round (40%)
- Seed (20%)
Country Focus
- United States (60%)
- Switzerland (40%)
Industry Focus
- Biotechnology
- Agtech
- Therapeutics
- Genetics
- Health Diagnostics
- Human Computer Interaction
- Medical Device
- Agriculture
- Chemical Engineering
- Farming
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
